Share
News

US Signs Deal To Receive Mass Quantity of COVID-19 Vaccine Doses Within Months

Share

Health and Human Services Secretary Alex Azar announced Wednesday that the U.S. has signed a contract with Pfizer for delivery in December of the first 100 million doses of a COVID-19 vaccine the pharmaceutical company is working to develop.

The U.S. could buy another 500 million doses under the agreement, Azar said.

“Now those would, of course, have to be safe and effective” and be approved by the Food and Drug Administration, Azar said during an appearance on Fox News.

Pfizer Inc. and BioNTech SE announced separately that the agreement is with HHS and the Defense Department for a vaccine candidate the companies are developing jointly.

The agreement is part of President Donald Trump’s Operation Warp Speed vaccine program, under which multiple COVID-19 vaccines are being developed simultaneously.

Trending:
I Miss Melania: Jill Biden Unveils Horrible Christmas Decorations for White House

The program aims to deliver 300 million doses of a safe and effective COVID-19 vaccine by January 2021, according to HHS.

Under the initiative, the government will speed development and buy vaccines — before they are deemed safe and effective — so that the medication can be in hand and quickly distributed once the FDA approves or authorizes its emergency use.

Pfizer and BioNTech said the U.S. will pay $1.95 billion upon receipt of the first 100 million doses, following FDA authorization or approval.

Azar said the contract with Pfizer and BioNTech brings to five the number of potential coronavirus vaccines that are under development.

Do you think a COVID-19 vaccine will be available by the end of the year?

Trump said Tuesday at a briefing that “the vaccines are coming, and they’re coming a lot sooner than anyone thought possible, by years.”

But other countries are also scrambling to get their hands on a vaccine for COVID-19, which has killed more than 617,000 people, according to a tally kept by Johns Hopkins University.

Nearly 4 million Americans have been infected by the new coronavirus and at least 142,000 have died from COVID-19, the disease it causes, according to Johns Hopkins.

Britain announced Monday it had secured access to another 90 million experimental COVID-19 vaccines made by Pfizer and others.

But some campaigners warned this move could worsen a global scramble by rich countries to hoard the world’s limited supply of COVID-19 vaccines.

Related:
Vaccine Evangelists Will Recoil in Horror After Vaccinated Individual Brings Omicron to America

Nearly two dozen potential vaccines are in various stages of human testing worldwide.

A handful have entered necessary late-stage testing to prove effectiveness.


[jwplayer jjQQVZiQ]

The Western Journal has reviewed this Associated Press story and may have altered it prior to publication to ensure that it meets our editorial standards.

Truth and Accuracy

Submit a Correction →



We are committed to truth and accuracy in all of our journalism. Read our editorial standards.

Tags:
, , , , , , , ,
Share
The Associated Press is an independent, not-for-profit news cooperative headquartered in New York City. Their teams in over 100 countries tell the world’s stories, from breaking news to investigative reporting. They provide content and services to help engage audiences worldwide, working with companies of all types, from broadcasters to brands.
The Associated Press was the first private sector organization in the U.S. to operate on a national scale. Over the past 170 years, they have been first to inform the world of many of history's most important moments, from the assassination of Abraham Lincoln and the bombing of Pearl Harbor to the fall of the Shah of Iran and the death of Pope John Paul.

Today, they operate in 263 locations in more than 100 countries relaying breaking news, covering war and conflict and producing enterprise reports that tell the world's stories.
Location
New York City




Conversation

The Western Journal is pleased to bring back comments to our articles! Due to threatened de-monetization by Big Tech, we had temporarily removed comments, but we have now implemented a solution to bring back the conversation that Big Tech doesn't want you to have. If you have any problems using the new commenting platform, please contact customer support at commenting-help@insticator.com. Welcome back!